John Wroblewski, MD
Ophthalmology · Hagerstown, MDNPI 1477521334
Payments from drug & device makers
What this record shows
This record is dominated by other: $11,370 of the $14,468 with a category attached, or 78.6%. Alcon accounts for 78.6% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $11,415, more than ten times the $141 reported in 2019. Among ophthalmology clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 40 payments — averaging $361.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$11K
- Cardinal Health 108 LLC$2K
- Notal Vision, Inc.$591
- AbbVie$208
- Topcon Healthcare, Inc.$172
- Genentech USA, Inc.$106
- plus $445 from 9 others
Across 7 payments — averaging $8276.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$58K
What the payments were for
- Consulting fees$1,57511%
- Speaking & faculty fees$5914%
- Food & beverage$9326%
- Other$11,37079%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 1 | $11,370 |
| Cardinal Health 108 LLC | 1 | $1,575 |
| Notal Vision, Inc. | 1 | $591 |
| AbbVie(2 entities) | 11 | $208 |
| Topcon Healthcare, Inc. | 1 | $172 |
| Genentech USA, Inc. | 5 | $106 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $95 |
| Novartis | 5 | $83 |
| Eyepoint US, Inc. | 2 | $59 |
| Bausch & Lomb Americas Inc. | 3 | $56 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Thrombogenics, Inc. | 1 | $34 |
| Astellas Pharma US Inc | 1 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
How this compares
$14,468 in reported general payments places this provider in the 90th percentile of 493 ophthalmology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 12 | $820 |
| Prednisolone Acetate | 16 | $659 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 14 | $636 |
| Atropine Sulfate | 12 | $410 |
| Clindamycin Hcl | 13 | $166 |
| Ketorolac Tromethamine | 12 | $133 |
| Timolol Maleate | 12 | $64 |
| Latanoprost | 11 | $58 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Hagerstown
- Allen HuHagerstown$379K
- David WarrowHagerstown$78K
- Jay BerdiaHagerstown$38K
- Alfred SommerBaltimore$2.9M
- Richard AdlerBaltimore$2.7M
- Peter McDonnellBaltimore$1.4M
- Esen AkpekBaltimore$782K
- Lisa FeulnerBel Air$434K
- Susan BresslerLutherville$341K
- Renee BovelleGlenn Dale$292K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.